DocDollars

Pharmacyclics LLC, An Abbvie Company

CA · United States · Reporting entity ID 100000136439

Total reported 2019–2025
$713.8M
#23 of 2,960 reporting companies — 0.9% of all reported industry payments
$6.08M in general payments across 50,158 records, plus $707.7M in research funding across 18,074 records.

How it breaks down

General payments $6,076,828
Research funding $707,736,888

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Pharmacyclics LLC, An Abbvie Company reported $713.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #23 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 50,158 general payment records and 18,074 research records were filed.

Common questions about Pharmacyclics LLC, An Abbvie Company

How much has Pharmacyclics LLC, An Abbvie Company paid US doctors?

Pharmacyclics LLC, An Abbvie Company reported $713,813,716 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,076,828 in general payments, $707,736,888 in research funding.

How does Pharmacyclics LLC, An Abbvie Company rank among drug and device companies?

It ranks #23 of 2,960 reporting entities by total reported value, about 0.9% of all industry payments in the dataset.

Does a payment from Pharmacyclics LLC, An Abbvie Company mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.